chevron_leftBack
As of 22 June 2026, Taiwan Bio Therapeutics Co., Ltd. has a market cap of $72.04M USD, ranking #27890 globally and #1610 in Taiwan.
It ranks #2517 in the Healthcare sector, and #486 in the Biotechnology industry.
Key Stats
Market Cap
$72.04MUSD
2.28B TWD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Founded
2014
Website
twbio-thera.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.1% | 2.7% | -3.6% | -8.2% | -12% | -15% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6892
台寶生醫股份有限公司
ISIN: TW0006892003
Shares Out.:
Shares Outstanding:
84.605M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25.90 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Taiwan Bio Therapeutics Co., Ltd.
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.45B
7K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
2K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.07B
1K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$724.27M
905%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$598.62M
731%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$569.71M
691%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
253K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
222K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
66K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.62B
62K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.24B
59K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.9B
58K%
33.71B CHF
|
37.2
|
chevron_leftBack